A Phase 1, First Time in Humans Study of NST-1024

NCT04630366 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia

Interventions

DRUG: NST-1024
DRUG: Placebo

Sponsor

NorthSea Therapeutics B.V.